Along with the latest news, today David talks to the UBC scientist linked to the promising BioNTech COVID-19 vaccine. Dr. Thomas Madden (CEO of Acuitas Therapeutics) talks about the new breakthrough they say is 90% effective.
Along with the latest news, today David talks to the UBC scientist linked to the promising BioNTech COVID-19 vaccine. Dr. Thomas Madden (CEO of Acuitas Therapeutics) talks about the new breakthrough they say is 90% effective.